First Trust Capital Management’s CERo Therapeutics CERO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-213	Closed	-$4.38M	–	248
2022 Q4	$4.38M	Buy	213 +14	+7%	+$288K	0.24%	135
2022 Q3	$4.01M	Buy	199 +23	+13%	+$464K	0.19%	162
2022 Q2	$3.53M	Buy	+176	New	+$3.53M	0.25%	117